Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
January 8, 2019
Novus Therapeutics Doses First Patient with Acute Otitis Media in Phase 1 Study of OP0201
IRVINE, Calif.--(BUSINESS WIRE)--Novus Therapeutics, Inc. (NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), ...
January 8, 2019
electroCore Announces Two New Studies and a Publication Supporting the Practical Utility of Non-invasive Vagus Nerve Stimulation in Adults
BASKING RIDGE, N.J., Jan. 08, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (ECOR), a commercial-stage bioelectronic medicine company, today announced two clinical studies focused on expanding ...
January 3, 2019
Cormedix Announces Closing of $7.5 Million Senior Secured Convertible Debt Financing
BERKELEY HEIGHTS, NJ / ACCESSWIRE / January 3, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products ...
January 3, 2019
Reata Announces Clinical Trial Design for FALCON, a Phase 3 Trial of Bardoxolone Methyl for the Treatment of Autosomal Dominant Polycystic Kidney Disease
IRVING, Texas, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA), a clinical-stage biopharmaceutical company, today announced that it has completed a successful end-of-Phase ...
January 3, 2019
Chiasma Previews Important Upcoming Milestones
WALTHAM, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Chiasma, Inc. (CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and ...
January 3, 2019
DURECT Corporation Announces Investor Call to Provide Corporate Update
CUPERTINO, Calif., Jan. 3, 2019 /PRNewswire/ -- DURECT Corporation (DRRX) invites interested parties to listen to a corporate update conference call that will be broadcast live ...
January 3, 2019
Kiadis Pharma to present at Biotech Showcase 2019
Amsterdam, The Netherlands, January 3, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical-stage biopharmaceutical company, today ...
January 3, 2019
AC Immune Announces Appointment of Dr. Marie Kosco-Vilbois as Chief Scientific Officer
Lausanne, Switzerland, January 3, 2019 - AC Immune SA (ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on Neurodegenerative Diseases, today announced ...
January 3, 2019
UroGen Pharma Appoints Elizabeth (Liz) Barrett as President and Chief Executive Officer
UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a focus on uro-oncology, today ...
January 3, 2019
ProQR to Host R&D Day in New York on January 29
LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (PRQR) will host a Research & Development Day for investors on ...
January 3, 2019
Chongqing Jingdong Pharmaceutical and Athenex Announce a Strategic Partnership and Licensing Agreement to Develop and Commercialize KX2-391 in China
BUFFALO, N.Y., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies ...
January 3, 2019
Arcturus Therapeutics Appoints Andrew Sassine as Chief Financial Officer
SAN DIEGO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (ARCT), a leading RNA medicines company focused on the development and commercialization of therapeutics ...
January 3, 2019
Kitov Signs Marketing and Distribution Agreement for its Lead Product Consensi™ in the U.S. with Coeptis Pharmaceuticals
TEL AVIV, Israel, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Kitov Pharma (NASDAQ/TASE: KTOV), an innovative pharmaceutical company, today announced it has signed an exclusive marketing ...
January 3, 2019
OncoCyte Announces Transition to Ion Torrent Next-Generation Sequencing Platform
ALAMEDA, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the early detection of cancer, ...
January 3, 2019
EDAP TMS SA : John Wayne Cancer Institute First US Medical Center to Acquire EDAP's Breakthrough Focal One® Technology for Prostate Tissue Ablation
LYON, France -- January 3, 2019 - EDAP TMS SA (EDAP) today announced that the John Wayne Cancer Institute (JWCI) at the Providence Saint John's ...
January 3, 2019
Cellectar Biosciences to Present at the Biotech Showcase
FLORHAM PARK, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of ...
January 3, 2019
InflaRx Continues U.S. Expansion with Addition of New York City Corporate Office and Addition of Management
JENA, Germany and NEW YORK, Jan. 03, 2019 (GLOBE NEWSWIRE) -- InflaRx N.V. (IFRX), a biopharmaceutical company developing innovative therapeutics to treat devastating inflammatory diseases ...
January 3, 2019
OSE Immunotherapeutics to present at Biotech Showcase™ 2019 Conference
NANTES, France, Jan. 03, 2019 (GLOBE NEWSWIRE) --  OSE Immunotherapeutics(ISIN: FR0012127173; Mnémo: OSE), today announced that Alexis Peyroles, CEO, will present an overview of the ...
January 3, 2019
Onxeo Announces Identification of Predictive Biomarkers for AsiDNA™, its First-in-Class DNA Damage Response Inhibitor
Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the Company”), a clinical-stage biotechnology company specializing in the development of innovative drugs in oncology, in ...
January 2, 2019
Acer Therapeutics Announces In-license of Osanetant from Sanofi
NEWTON, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for ...
Page 1 of 120